Pritoxaximab (Anti-Shiga toxin (E.coli)) is a human chimeric IgG1(kappa) antibody that target shiga toxin 1 and shiga toxin 2, produced by E. coli. It can be used in the treatment of hemolytic-uremic syndrome (HUS). MW :145.88 KD.